A New Generation of Antibiotics

Developing innovative treatments to stay ahead of bacterial resistance and protecting global health

smartbax at glance

smartbax is a German biotech startup, founded in Munich in 2021, dedicated to developing innovative antibiotics to combat the rising threat of multidrug-resistant bacteria. Our vision is to create smarter antibiotics for a healthier tomorrow. By combining cutting-edge technology with deep scientific expertise, our team designs drugs to outsmart bacterial resistance – addressing one of the most urgent threats to global health. At smartbax, we believe preventing a crisis tomorrow means taking action today.

Mission

Our mission is to develop a new generation of small-molecule antibiotics that outsmart bacteria and overcome antimicrobial resistance.

Strategy

We target hydrolytic processes that bacteria rely on for survival. By focusing exclusively on novel protein targets outside classical pathways, we unlock new mechanisms to effectively eliminate multi-drug resistant bacteria.